MetLife Investment Management’s Clearside Biomedical CLSD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,859	Closed	-$116K	–	2612
2018 Q2	$116K	Hold	10,859	–	–	﹤0.01%	2153
2018 Q1	$117K	Buy	+10,859	New	+$117K	﹤0.01%	2135